01521.HK
Frontage Holdings Corporation
HKSE · Healthcare · Biotechnology · US
HKD 1.49
+13.31%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 17.46x
- P/E 2027E
- 16.25x
- P/E 2028E
- 18.84x
- P/S forward
- 2.56x
Trailing multiples
Trailing twelve months
- P/E TTM
- 36.53x
- PEG TTM
- —
- Price / book
- 1.09x
- Price / sales
- 1.39x
- Price / cash flow
- 7.58x
Enterprise value
- Enterprise value
- HKD 3.8B
- EV / sales
- 1.76x
- EV / EBITDA
- 8.48x
- EV / EBIT
- 22.38x
- Market cap
- HKD 3.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026